Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002555

Options or other derivatives

  • HEAD OF R&D acquired 496,204 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
MODUR VIJAY HEAD OF R&D 2021-05-18 Grant or award · Stock Options (Right to Buy) +496,204 496,204 D
Loading xslF345X03/form4-05182021_020547.xml…